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Adaptor protein complex 2 a and b-appendage domains act as hubs for the assembly of accessory protein networks
involved in clathrin-coated vesicle formation. We identify a large repertoire of b-appendage interactors by mass
spectrometry. These interact with two distinct ligand interaction sites on the b-appendage (the ‘‘top’’ and ‘‘side’’ sites)
that bind motifs distinct from those previously identified on the a-appendage. We solved the structure of the b-
appendage with a peptide from the accessory protein Eps15 bound to the side site and with a peptide from the
accessory cargo adaptor b-arrestin bound to the top site. We show that accessory proteins can bind simultaneously to
multiple appendages, allowing these to cooperate in enhancing ligand avidities that appear to be irreversible in vitro.
We now propose that clathrin, which interacts with the b-appendage, achieves ligand displacement in vivo by self-
polymerisation as the coated pit matures. This changes the interaction environment from liquid-phase, affinity-driven
interactions, to interactions driven by solid-phase stability (‘‘matricity’’). Accessory proteins that interact solely with
the appendages are thereby displaced to areas of the coated pit where clathrin has not yet polymerised. However,
proteins such as b-arrestin (non-visual arrestin) and autosomal recessive hypercholesterolemia protein, which have
direct clathrin interactions, will remain in the coated pits with their interacting receptors.
Citation: Schmid EM, Ford MGJ, Burtey A, Praefcke GJK, Peak-Chew SY, et al. (2006) Role of the AP2 b-appendage hub in recruiting partners for clathrin-coated vesicle
assembly. PLoS Biol 4(9): e262. DOI:10.1371/journal.pbio.0040262
Introduction
Clathrin-mediated endocytosis is the process whereby
cargo molecules are selected for incorporation into vesicles
surrounded by a coat protein, clathrin. ‘‘Accessory proteins’’
organise the process of coat assembly and disassembly as well
as the process of membrane budding and ﬁssion [1–5]. Some
of these accessory proteins act as ‘‘cargo adaptors’’ and help
select the cargo content of the nascent vesicle. In synaptic
vesicles there are over ten different transmembrane cargo
components, each in their constant stoichiometries and
packaged in vesicles of uniform size to ensure reliable
synaptic transmission [6,7]. This is a remarkable achievement
of the clathrin-adaptor machinery. Thus we are seeking an
understanding of the biogenesis of the synaptic vesicle
organelle (and indeed clathrin-coated vesicles in general)
and the principles of how accessory cargo adaptors and other
accessory proteins are organised to achieve vesicle formation.
Clathrin-coated vesicle (CCV) formation is frequently
viewed as a linear series of steps culminating in the detach-
ment of a vesicle from the parent membrane. However the
initial steps of cargo concentration, membrane invagination
and coat assembly likely occur in parallel and, to achieve this,
many proteins must work together [8]. For proteins involved
in the various aspects of CCV formation this cooperation
necessitates many interconnections and the process is best
described as a dynamic network. When we plot the
characterised possible protein interactions in endocytosis,
ignoring the competition and spatial constraints, we obtain
an ‘‘endocytic interactome’’ (see scheme, Figure 1). In the
endocytic interactome some proteins have disproportion-
ately large numbers of interaction partners and these are
classiﬁed as ‘‘hubs’’ [9]. The tetrameric adaptor protein
complex 2 (AP2) and clathrin are examples of such hubs in
this network.
There are four AP complexes used in different trafﬁcking
pathways (AP1–AP4) each having two large subunits (adap-
tins: c, a, d, e, and b1–4) and two smaller subunits (l1–4 and
r1–4; see reviews above and schematic of AP2 in Figure 1B).
The core domain (trunk) of each complex interacts with both
PtdInsPs and cargo (predominantly via the l and a-subunits)
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PLoS BIOLOGYFigure 1. New Protein Interaction Partners for the a- and b-Appendage Domains of AP2 Adaptors
(A) Plot of the network of protein interactions in clathrin-mediated endocytosis. AP2 adaptors and clathrin have disproportionately large numbers of
interactors and so are the hubs of this network. Dynamin is a ‘‘party’’ hub as it is shared between different networks but we have not included all its
interactors.
(B) Scheme of AP2 showing the overall domain architecture and the appendages where most of the protein interactors bind are located on flexible
linkers called ‘‘hinges.’’
(C) Protein interactors of a- and b2 appendages from HeLa cells as determined by LC-MS/MS of Coomassie stained bands. Bolded proteins were not
detected previously. The interaction of CVAK104 and CVAK90 were tested and confirmed by yeast-2-hybrid analysis. The numbers of peptides
sequenced from each protein are given in brackets. Further mass spectrometry data from brain and liver samples, accession numbers, domain
structures and details are given in Figures S1 and S2.
DOI: 10.1371/journal.pbio.0040262.g001
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Changing Hubs in CCP Maturationthereby anchoring it to membranes [10]. The C-terminal
‘‘appendage domains’’ of the large subunits recruit inter-
action partners from the cytosol facilitating their concen-
tration at sites of coated pit formation. Appendage domains
are found at the ends of ﬂexible linkers (hinge domains) that
extend from the core of the adaptor complex. This provides
the opportunity to search a wide area of surrounding
cytoplasm for accessory proteins including other cargo
adaptors (see http://www.endocytosis.org/Adaptors/
Appendages.html for structural aspects).
In our previous work we investigated how the a-appendage
interacts with its many binding partners [8] and found that
some proteins interact tightly with isolated a-appendage
domains while others interact more effectively when appen-
dages are concentrated, as occurs during clathrin-coated pit
(CCP) formation. Each a-appendage has at least two distinct
interaction sites for short linear peptide motifs (see also [11]).
If a single interaction partner occupies both sites then that
allows interactions with a higher avidity (a value that is
between the sum and the product of the afﬁnities for each
site). Given that the multiple peptide motifs are generally
found in unstructured domains, this provides a mechanism
for generating high avidity and readily reversible interac-
tions. We proposed that during coated pit assembly many
different accessory proteins will interact simultaneously with
t h eA P 2h u b( m a d eu po fc o n c e n t r a t e dA P 2 s )b u ti n
stoichiometries related to their afﬁnities and concentrations.
In this view the AP2 a-appendage is not initially a hub in
solution but has the properties of a hub only during CCP
formation, and again rapidly loses these properties when
clathrin is recruited and polymerised. Thus AP2 is a hub only
at initial stages of network assembly and these AP2 hub
assembly zones are found at the leading edges of CCP
formation [8].
In this paper we are interested in the organisation of the
endocytic interactome and therefore in the repertoire of AP2
interactors in brain and non-brain tissues and by extension in
synaptic vesicle endocytosis and receptor-mediated endocy-
tosis. We ﬁnd that in an AP2 complex the b2-appendage
works in partnership with the a-appendage to bind a similar
but not identical subset of appendage ligands, thereby
extending the interaction repertoire. The b-appendage
collaborates with the a-appendage in pulling partners to
sites of pit assembly. The b-appendage has an additional
function as a unique clathrin assembly platform [12,13] that
results in the displacement of b-ligands despite the low
afﬁnity of the appendage for clathrin. This ensures the coated
pit matures from an initial assembly zone to a clathrin-coated
pit. By structural analysis we elucidate the modes of ligand
interactions with the b-appendage. We speculate on how the
relative afﬁnities and avidities of accessory proteins are
superseded by the matrix interaction of polymerised clathrin.
We see the process gradually moving from liquid-phase
dynamics in the cytoplasm, through membrane-anchored
dynamics to more solid-phase dynamics as clathrin polymer-
ises around the nascent vesicle. Here we refer to the protein
interactions in this maturation as moving from afﬁnity (as
measured by the simple interactions of one protein with
another), through avidity (the interaction of clustered
components with multivalent ligands) to ‘‘matricity’’ (the
interaction of a matrix with its environment).
Results
Ligands of the b-Appendage
The AP2 adaptor complex with its two appendages acts as
an interaction hub for numerous accessory proteins, whether
these be accessory cargo adaptors or accessory proteins
involved in the mechanics of CCV formation. We have
previously carried out chromatography tandem mass spec-
trometry (LC-MS/MS) analysis for a-appendage ligands in
brain extract [8] and c-appendage ligands in brain extracts
have been analysed by the group of Robinson [14]. We have
extended this using glutathione S-transferase (GST) a and b2
appendages coupled to agarose beads in HeLa, brain and liver
extracts (Figure 1C and Figure S1), and analyse the protein
interactors with LC-MS/MS. Over 20 different proteins are
found in the b2-appendage pull-down from HeLa cell
extracts (Figure 1C). These include clathrin, intersectin1
and 2, c-synergin, AAK, Eps15, Eps15R, aftiphilin, Dab2/
Disabled2, epsin and epsinR, RalBP1, Hsc70, sorting-nexin9
(snx9), HivRevBP, and Tom1, along with some proteins not
yet named (KIAA1219, KIAA1558, KIAA1096), and a kinase
like protein called Scy1-like1. Many of these have not been
observed before (highlighted in bold in Figure 1C). There is a
surprising overlap of binding partners with the a-appendage,
but there are also unique protein interactors for each
appendage. In the HeLa cell pull-down 25% of the b2
interactors are not found on a. We have also found some new
interaction partners for the a-appendage not detected in our
previous analysis of a-ligands in brain extract (including
epsin2, pacsin/syndapin2, Scy1-like1 and Scy1-like2, Sec23
interacting protein p125, RanGAP1, Znﬁnger protein, and
ArfGAP1), along with some proteins not yet named
(KIAA0592, KIAA1033, KIAA0196). This might reﬂect the
greater abundance of some of these proteins in HeLa cells.
KIAA1414 was found in the rat brain b2-appendage pull-
down (Figures S1 and 2) and this has previously been noted as
a component of CCVs [15]. KIAA0685, a SAPS domain
containing protein, is also found in rat brain pull-downs and
is related to KIAA1558 found in the HeLa cell pull-downs.
The pull-down experiments do not prove that all of these
newly identiﬁed interactors are direct. However the majority
of interactors contain domains that are predicted to be
largely unstructured and by sequence analysis contain
multiple repeats of the type that we already know interact
with a-appendages (we call these ‘‘motif domains’’, see also
Figure S2). One protein that we ﬁnd in a- and b-appendage
pull-downs from HeLa, liver and brain extracts is Scy1-like1.
This is a distant homologue of Scy1-like2 which is found only
in a-appendage pull-downs (Figure 1C). There is 16% amino
acid identity between Scy1-like1 and 2. Scy1-like2 was
previously found in CCVs and was thus renamed as
clathrin-coated vesicle associated kinase of 104kDa
(CVAK104)[16]. Scy1-like1 contains multiple DxF motifs of
the type that bind to the top site of the a-appendage and thus
is likely to function in CCV formation. To retain nomencla-
ture we call it CVAK90 (as the longest human splice form is
predicted to be 90kDa). We veriﬁed a direct interaction of
CVAK104 and CVAK90 with both the a- and b-appendages
using yeast-2-hybrid (unpublished data).
Our pull-down experiments so far have examined the
interaction partners of appendages from the AP2 complex.
The AP1 complex has c- and b1-appendage domains. b1- and
PLoS Biology | www.plosbiology.org September 2006 | Volume 4 | Issue 9 | e262 1534
Changing Hubs in CCP Maturationb2-appendages share over 70% amino acid identity and in
our experiments they interact with a similar range of proteins
(Figure 1C and Figure S1B). Previously reported c-appendage
interactors like c-synergin and aftiphilin [17–21] also bind to
b-appendages but not strongly to the a-appendage in our
pull-downs. Thus they will form stronger networks with c and
b1 and therefore get selected for AP1-CCV formation.
We see from this data that the accessory cargo adaptor
Dab2/Disabled2 (a cargo adaptor for proteins like megalin)
binds to both a and b appendages, and it is likely that some of
the other accessory proteins that bind to both a and b
appendages will also have cargo adaptor status. Thus a view
that accessory cargo adaptors interact exclusively with the b-
appendage cannot be generalised. Nevertheless some acces-
sory adaptors like b-arrestin (for internalisation of G-protein
coupled receptors [GPCRs]) and autosomal recessive hyper-
cholesterolemia protein (ARH; for internalization of LDL
receptors) bind to the b-appendage alone [22–24]. We do not
detect them here, presumably because of the low abundance
of these proteins in HeLa cells.
The few differences in the major ligands found in brain
extracts compared with HeLa cell extracts (Figure 1C and
Figure S1) show that CCV formation in the brain is not so
extremely specialised. Nevertheless we do ﬁnd differences,
like the abundance of amphiphysin and AP180 in a-pull-
downs from brain, compared with sorting-nexin9 and CALM
in non-neuronal tissues.
Many of the a-appendage binding partners were also b-
partners and thus there is not the degree of protein selectivity
between the appendages we had expected. Since two different
appendages appear to be necessary we need to understand
why, and thus we investigate the modes of ligand interactions.
Two Interaction Sites for New Motifs on the b-Appendage
Protein-protein interaction surfaces are more highly
conserved than surrounding areas. We have used this
conservation of surface residues in our previous analysis of
the a-appendage to predict binding sites and now extend the
same analysis to the b-appendage using sequences extending
from yeast to man. There is a conserved site on the platform
sub-domain of the appendage (top site) and on the side of the
b-sandwich sub-domain (side site, Figure 2A). The top site is
in a comparable position in a and b2 (for mutagenesis see
[13]) but the side site is almost on the opposite side of the b-
sandwich compared to the corresponding side site of a.
We made critical point mutations of the interaction sites
and looked at a variety of ligands using pull-downs and
Western blotting. Mutation of a tyrosine on the side site
(Y815A) of the b2-appendage was highly effective at displac-
ing amphiphysin, Eps15 and AP180 (Figure 2B). Mutation of
surrounding lysines to glutamates also weakened these
protein interactions. b-Arrestins have previously been pro-
Figure 2. The b2-Appendage Has Top and Side Sites for Protein
Interactions
(A) Surface residues that are conserved from yeast to man are coloured
from maroon (highly conserved) through white to sky-blue (least
conserved). The a-appendage is shown for comparison. Both have two
conserved patches, a top site and a side site.
(B) Mutants of top and side sites in b compared with mutants of a. GST
wild-type and mutant appendages were used in pull-downs from brain
extract. b-arrestin binds specifically to the top site of b2, while most
other ligands appear to bind more tightly to the side site.
(C) Coomassie gel analysis of protein interactors with a- and b2-
appendages from brain extracts. The boxed areas show the most
effective mutants at displacing ligands. Asterisks mark positions of co-
purified chaperones.
DOI: 10.1371/journal.pbio.0040262.g002
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Changing Hubs in CCP Maturationposed to bind speciﬁcally to the b-appendage and are not
displaced by these side site mutants. Whereas b-arrestin is
completely displaced by the top site mutant Y888V, amphi-
physin, Eps15, AP180, and epsin1 are only weakened by this
same mutation. Thus these ligands must have interaction
motifs for both the top site and the side site. Two interaction
sites were also found in a recent publication [25] but the
authors believe these sites are independent. Several top site
mutants showed a stronger interaction with ligands. While
R879A binds with a higher afﬁnity to b-arrestin, K842E binds
with a higher afﬁnity to Eps15 and a lower afﬁnity to AP180
and amphiphysin. From these mutants we conclude that this
top site has several different modes of interaction and this ﬁts
with the extensive nature of the conserved interaction
surface.
A comparison of Coomassie-stained interactors of the main
mutants of top and side sites in both a and b2 appendages
(Figure 2C) shows that the main ligand interaction site on a is
the top while the main interaction site on b is the side.
Multiple Interaction Sites Lead to Increased Avidity
We started to examine the on- and off-rates for ligand
interactions with appendages using surface plasmon reso-
nance (SPR) where a-o rb-appendages were coupled to chips
and the motif domain of Eps15 (Eps15-MD, which covers the
unstructured region, residues 530–791) was allowed to
interact (Figure 3). In both cases the Eps15-MD bound so
tightly that the off-rate cannot be measured as it takes more
than 1 h to signiﬁcantly reduce the binding (Figure 3A). This
is also seen from empirical observations that in pull-downs
using agarose bead-bound appendage domains most ligands
do not wash off easily even after very extensive periods (up to
30 min, unpublished data). We assume that these observations
of tight interactions are due to the presence of multiple
appendage interaction sites in a single protein domain (for
Eps15 we have previously identiﬁed four sites for a) [8]. Thus
if the appendages are linked or bound to the same surface we
observe a high avidity for the ligand interaction that is much
stronger than the sum of the individual afﬁnities [8]. This
means that even a weak afﬁnity can make a very signiﬁcant
contribution to a protein interaction, as long as there are
multiple copies. This could be considered an artefactual
observation, given the concentration of the appendages on a
bead or on a SPR chip, but AP2 adaptors have two
appendages and adaptor complexes are concentrated at sites
of endocytosis and thus here they also present multiple
appendages for interaction with ligands. Our observations of
picomolar afﬁnities for the monomeric Eps15-MD may not be
accurate given that we do not observe an accurate off-rate,
however this is likely to be an underestimate of the afﬁnity of
full-length Eps15 for AP2 as this protein is a dimer [26]. This
is likely to have a physiological signiﬁcance in giving stability
to coated pit assembly, but this glue-like interaction also
posits a signiﬁcant problem for the progression of coated
vesicle formation and the displacement of accessory proteins
during the maturation of the coated pit.
A Ligand Interaction Site on the b-Sandwich Domain of
the b-Appendage
To understand appendage interactions we need a more
detailed molecular description. By mass spectrometry inter-
actions with Eps15, intersectin, RalBP1, and HivRevBP are
still present in top site mutants and not with the side site
mutant (unpublished data) and thus they interact predom-
inantly with the side site. Knowing that Eps15 interacts
primarily with the side site of the b-appendage (see also
Figure 2B) we tested Eps15-MD (Figure 3C and 3D). We found
that two appendages could interact with each copy of this
domain with afﬁnities of around 20 lM [8]. This interaction
was abolished by a side site mutant and unaffected by a top
site mutant (Figure 3C and 3D, note that we have used full-
length Eps15 protein in Figure 2B). Thus we conﬁrm a
speciﬁc interaction of Eps15 with the side site of the b-
appendage. To further narrow the interaction sequence we
tested a number of peptides (previously made to test the
interaction with the a-appendage) and found peptides that
can interact with the b-appendage (Eps15 P-long and P-
short). A mutant of the side site abolished the interaction
(Figure 3D, Eps15 P-short).
We obtained co-crystals for Eps15 P-short peptide
(SFGDGFADFSTL) with the b-appendage and see density
for the complete peptide (Figure 4 and Table S1). The
peptide forms a tight turn with the side-chains of F2 and F9 in
a groove and that of F6 lying against a shallow pocket. The
tight turn is formed by G5, and the psi and phi angles for this
residue lie in a region of the Ramachandran plot permitted
only for glycine residues. The turn is stabilised by the side
chain of D8: it forms hydrogen bonds with the backbone
nitrogen atoms of G3 and G5. The D8 side chain also forms a
hydrogen-bond with Y815 of the appendage giving speciﬁcity
to the peptide. The main chain carbonyl group of D8 also
forms a hydrogen-bond with Q758. F2 is surrounded by N758,
Q804, V805, A806 and Y815 where A806 is found in the base
of the groove. F6 makes a hydrophobic interaction with V813.
F9 projects into a shallow pocket lined by A754, Q756, K808,
and V813. From F6 onwards, the peptide forms one turn of a-
helix before the density fades. There were two b-appendage
molecules in the asymmetric unit and consequently the
peptide binding sites are in different crystallographic
environments. The peptide we describe (that bound to
molecule A) is sandwiched between the two molecules but is
mostly bound to A. There are a few stabilising interactions
with residues from B. We observe hydrogen bonds from the
backbone nitrogen of chain B L819 and the ring nitrogen of
chain B W714 to the side chain of D4 along with some other
interactions via water molecules, as well as some interactions
with the partially exposed F6. Molecule B has the Eps15
peptide in an identical position despite the peptide being
exclusively solvent-exposed here. The density for this peptide
Figure 3. High Avidity Interactions of Eps15 for Clustered Appendages, yet Low Affinity Interactions of Ligands with Isolated Appendages
(A) Surface plasmon resonance measurements of Eps15-MD binding a and b-appendages. Note that the protein binds, but does not come off even after
extensive washing.
(B) Affinities of b-arrestin P-long (see D) for wild-type b2-appendage and mutants measured by ITC.
(C) Affinity measurement of protein domains with b2-appendages.
(D) Table of peptides used, highlighting possible motifs, and a summary of affinities.
DOI: 10.1371/journal.pbio.0040262.g003
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Changing Hubs in CCP Maturationis weaker here so it is possible that the binding site on this
molecule was partially occupied (the KD being 46 lM).
However, we see density for two Fs in the same positions as
F2 and F9 in the peptide bound to molecule A. As the density
is weak it has not been possible to model this peptide
unambiguously.
Mutagenesis of this site conﬁrms that Y815 on the b-
appendage is a critical residue presumably as it p stacks with
F2 and H-bonds to D8. K808E also signiﬁcantly weakens the
interaction of amphiphysin, but has little effect on Eps15 as
expected from the structure (Figure 2B). K759 is also close to
the interaction site but is not involved in Eps15 peptide
binding. K719 is a conserved residue at the distal end of the
conserved patch and is not involved in peptide interactions
nor does it affect the interaction of any ligands tested.
We made a peptide from epsinR that has sequence
similarity to the Eps15 peptide. This epsinR peptide bound
with an 80 lM afﬁnity and a top site mutant does not reduce
this afﬁnity. Thus this is likely a side site interaction. To
further examine the role of D8 in the interaction we made
short peptides covering the FxDF sequence. An FADF 7mer
peptide bound with an afﬁnity of approximately 110 lM, and
a mutation of the D to G gave no binding. Based on our
structure we can propose that the FxDF peptide binds in a
conformation similar to the a-helical turn in our Eps15
peptide. Taken together we think that F9 can be separated
from the initial F2 by either a few residues and a tight turn (if
there is a glycine present) but conceivably there could be
more intervening residues, obviating the need for a glycine.
Also the hydrophobic residues could easily be replaced by
others of similar hydrophobicity. Thus the motif in Eps15 and
epsinR is of the form [F/L]xxGFxDF but it could also be [F/
L]xn[F/L]xDF, where n .3.
Folding of b-Arrestin C-Terminal Peptide into an a-Helix
on Interaction with the b-Appendage
Given the speciﬁcity of the b-arrestin interaction with the
top site of b (see also [27]), we made peptides based on data
from previous mutagenesis of the C-terminal tail of arrestin
[22,27–29] and tested the interaction with the b-appendage by
isothermal titration calorimetry (ITC). A b-arrestin peptide
(P-long: DDDIVFEDFARQRLKGMKDD) bound with an afﬁn-
ity of approximately 2 lM and this was completely abolished
by a top site mutant and not by a side site mutant of the b-
appendage (Figure 3B and 3D). We previously thought that a-
and b-top sites would interact with similar motifs, given the
conservation of the site [13] but an amphiphysin peptide
(Amph DNF 12mer) that binds with an afﬁnity of 2.5 lMt o
the top site of a via an FxDxF motif, shows no binding to b
(Figure 3D). Also b-arrestin P-long does not have a DxF or
FxDxF motif found in top site interactors of the a-appendage,
thus the binding modes must be different. To understand the
speciﬁcity of the b-appendage top site we solved the crystal
structure of b2-appendage in combination with b-arrestin P-
long (Figure 5 and Table S1).
b-Arrestin P-long peptide (DDDIVFEDFARQRLKGMKDD)
is derived from the C-terminus of b-arrestin and in crystal
structures of b-arrestin 1 and 2 [28,30] this region packs
against the N-terminal sub-domain of the arrestin molecule
in an extended conformation. By circular dichroism this
peptide, in solution, is not helical (unpublished data) but in
our b-appendage crystal structure the b-arrestin peptide is
folded as an a-helix in a groove between a-helix 1 and the
antiparallel b-sheet of the platform sub-domain (Figure 5A).
Thus the peptide folds on appendage binding. A similar
observation is seen for an ARH peptide bound to the b-
appendage in a paper just published [25]. In our structure of
the b-appendage:b-arrestin P-long co-complex, residues D3–
R13 were clearly visible and the induced helix breaks down
after the arginine residue. The main interacting residues on
the helix are D3xxF6xxF9xxxR13. All these residues lie on one
side of the helix. Our density for D3 is not well deﬁned but the
side-chain appears to make hydrogen bonds with R834 and
R879. F6 is in a hydrophobic environment created by F837,
L838, and I876. F9 projects into a hydrophobic space lined by
W841 and Y888. It shows p stacking with Y888 while W841 lies
at the base of this groove. Mutation of W841 is likely to
disrupt the local environment. The density at the base of F9 is
not well deﬁned, indicating some ﬂexibility. Indeed, in the
analogous sequence from ARH, an L occupies this position
(see also [25]). The guanidino group of R13 forms hydrogen
bonds with E849 and E902. L14 of the peptide, where the helix
breaks, interacts with V881. The core motif, as revealed by the
structure, is DxxFxxFxxxR, with the additional constraint that
this must be found in the context of an a-helix, unlike the
unfolded nature of peptide interactions known for other
appendages. It is now evident from the structure why the
mutation Y888V inhibits b-arrestin binding (see Figure 2B).
Other key interaction residues are E902 and E849 and have
been shown to be important in previous studies by others
[27,29]. We note that R879 moves substantially between the
unbound and the b-arrestin peptide-bound structure and a
R879A mutation results in a 10-fold stronger interaction with
b-arrestin (Figure 2B and 3C). The mutant is missing a
hydrogen bond to the peptide via the terminal guanidino
group of R879. Replacement of this side-chain may provide
more space for a tighter interaction of the peptide with the
groove. We shortened the arrestin peptide and although P-
short has the core motif, it does not bind (Figure 3D), possibly
because the peptide is too short to form a helix. The
disruption of the helix may have caused previous difﬁculties
in mapping the precise b-adaptin interacting residues on b-
arrestin [22,27]. The interaction motif is conserved in b-
arrestins 1 and 2 across different species (Figure 5F). Weak
binding to AP2 has been reported for (bovine) visual arrestin
[22] even though the motif is not completely conserved
(Figure 5F). This motif is also found in the C-terminus of ARH,
although F9 is here an L. A peptide covering this motif in ARH
binds with a similar afﬁnity to arrestin (Figure 3D). By looking
at the homology of this motif across species it is likely to have
a more generic form of [E/D]xxFxx[F/L]xxxR. An A frequently
follows the second F and the initial D is often found with a
cluster of acidic residues, perhaps aiding interaction with the
generally basic potential of the surface of the b-appendage in
this region. Given that the necessity of the initial D is not clear
from the structure, we tested a mutant of this residue in ARH
for the afﬁnity of its interaction with b-appendage. The D to R
mutant has a 30-fold lower afﬁnity (Figure 3D and [25]).
Compared to wild-type appendage, the R879A mutant of the
b-appendage, which bound the b-arrestin peptide with higher
afﬁnity, does not have a different afﬁnity for ARH (likely due
to a serine after the ﬁrst F in ARH being easier to
accommodate near the interaction groove).
Scy1-like1 (CVAK90) has an FxxFxxxR sequence and Dab2/
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Changing Hubs in CCP MaturationFigure 4. Eps15 Peptide Binds in a Tight Turn to the Side Site of the b2-Appendage
(A) Ribbon diagram showing peptide in yellow bound to side site of the b-appendage.
(B and C) The two principle Phe residues of the peptide bind in a groove. A single turn of a helix can also be seen for this peptide.
(D) Peptide displayed as a linear chain showing hydrogen-bonding potential (green lines) and hydrophobic interactions (grey lines). A cluster of
hydrogen-bonds in the peptide is consistent with the a-helical conformation in this region.
(E) Density map for the peptide contoured at 1.24 r.
DOI: 10.1371/journal.pbio.0040262.g004
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spectrometry with the side site mutant but not with the top
site mutant. We conﬁrmed that Dab2/Disabled2 binds to the
top site by Western blotting (unpublished data). Tom1, found
as a b-appendage interactor in HeLa cells, also has an
EDxFxxFxxxR. Epsin1 binding to b-appendage is weakened
by Y888V top site mutant (Figure 2B). We found a possible
interaction motif in epsin1/2 (see Figure 5F) and made a
peptide covering this motif (see also [25]). This peptide
(epsin1 P3) has a similar low afﬁnity to b-appendage as the
ARH peptide with its D mutated (118 / 123 lM, see Figure 3D).
With this low afﬁnity there must be a second mode of
interaction required for efﬁcient epsin1 binding to the b-
appendage.
Based on the structure we made mutants of the b-arrestin
C-terminus, F388A and F391A. In our structure the equiv-
alent residues of the peptide both bind into the extended
hydrophobic groove on the b2-appendage. Both of these
mutants severely disrupt binding to the b-appendage (Figure
5E), conﬁrming our structural observations. R395 of b-
arrestin has previously been shown to be important for the
interaction [22,27]. While the b-arrestin C-terminus binds to
both clathrin and AP2 adaptors, we observe the clathrin
interaction is increased when adaptor interactions are
inhibited. Thus these interactions are likely to be mutually
exclusive and indeed the close proximity of the clathrin
terminal domain interaction motif (LIEFD, [31]) and adaptor
binding motifs on b-arrestin (there are seven intervening
residues) will result in stearic hindrance.
Linking Clathrin Assembly to Adaptor Clustering
Many clathrin and adaptor interaction sites on accessory
proteins overlap (including those of b-arrestin above), leading
to the possibility that accessory proteins may swap from the
AP2 appendage hub to the clathrin hub during coated pit
assembly. However one must deal with the high avidity of
accessory protein interactions with concentrated AP2 com-
plexes (see Figure 3A). Normally a higher afﬁnity interaction
is required to displace a previous one but given that in a
coated pit clathrin self-polymerises (at a critical concen-
tration), even low afﬁnity interactions of clathrin with the
appendages may be sufﬁcient to displace higher afﬁnity
ligands (see below for a more detailed discussion).
We previously reported that clathrin polymerises around
the b2-appendageþhinge causing displacement of other
interaction partners [13]. The ﬂexible ‘‘hinge’’ sequence
between the core of the adaptor complex and the appendage
has multiple clathrin terminal domain interaction motifs. We
also showed that clathrin interacts with the top site of the b-
appendage likely with a site C-terminal to the clathrin
terminal domain. Given that we now know that most ligands
of b bind to the side site we made a more extensive
assessment of the role of clathrin in ligand displacement
(Figure 6). In pull-down experiments (Figure 6A) clathrin is
highly enriched on the b2-appendageþhinge protein but is
not visible with the appendage alone in line with clathrin
interactions with both the appendage and the hinge. A
mutant of the top site, Y888V, reduces clathrin-binding
effectively (in accordance with [13]). A mutant of the side site
had a much weaker effect on clathrin binding (see lower
exposure of clathrin in Figure 6A) showing that the
predominant clathrin interaction with the appendage is with
the top site. In a recent paper it was concluded that clathrin
interacts with the side site, but in this study they have not
examined clathrin interactions with the top site mutants or
taken into account the previously published information, and
thus their conclusion on clathrin displacement are mislead-
ing [25]. When clathrin is bound to the appendageþhinge
then there is a reduction of b-arrestin, amphiphysin, and
AP180 binding. The displacement of Eps15 and epsin was
more variable (see epsin1 binding to b1-appendageþhinge in
Figure 6B) and is likely due to the high avidity and multiple
interaction sites of these proteins for b2-appendages (see also
Figure 3C and 3D). In Figure 6B the effect of clathrin
interaction with b1 is shown and there is a signiﬁcant direct
displacement of the top site interactor b-arrestin and a
reduced interaction of AP180, amphiphysin and epsin1. This
again points to the role of clathrin in the displacement of
accessory proteins as coated pits are formed.
Many accessory proteins have both adaptor-appendage and
clathrin terminal domain interaction motifs and thus we used
GST-clathrin terminal domain bound to sepharose beads in
pull downs from brain extract. This should allow us to ﬁnd
proteins that bind with a high avidity to multiple terminal
domains. Eps15 and dynamin have no clathrin interaction
motifs. AP180, amphiphysin and epsin1, which all have
clathrin interaction motifs, show no visible interaction with
clustered terminal domains (Figure 6C). This was a rather
unexpected ﬁnding. This shows that the afﬁnity between
clathrin terminal domains and most accessory proteins is not
high enough to be detected in pull-downs and thus clathrin is
unlikely to recruit these proteins to sites of endocytosis. We
then did the reverse experiment and used motif domains of
accessory proteins clustered on beads and found clathrin
does bind efﬁciently (Figure 6D). This is likely due to the
stabilization of clathrin through self-interactions. Thus these
proteins have the appropriate properties to recruit clathrin
when clustered at nascent pits.
In contrast to the above we do observe a higher afﬁnity of
auxilin and adaptor-associated kinase (AAK) on clustered
GST-clathrin terminal domains (Figure 6C). These proteins
are likely to be recruited primarily by clathrin over adaptors.
Auxilin is already known to be involved in uncoating and we
would also propose that AAK is likely a kinase working at this
same stage. AAK may function at multiple stages given that it
has previously been shown to phosphorylate the l2 subunit of
Figure 5. Peptide from the C-Terminus of b-Arrestin Folds as a Helix in a Groove on the Platform Sub-domain of the b2-Appendage
(A) Ribbon diagram showing peptide in purple bound to top site of the platform sub-domain of the b-appendage as an a-helix.
(B and D) The peptide binds into a groove with interacting residues of the peptide lining one side of the helix. The top of the groove is generally
positive and D3 of the peptide is found here. F6 and F9 are in apolar environments and there is limited space for F9.R 13 binds to the negatively charged
patch of the groove.
(C) Peptide displayed as a linear chain showing hydrogen-bonding potential (green lines) and hydrophobic interactions (grey lines). Hydrogen bonds
within the a-helix of the peptide are not shown for clarity. The residues for which there is little density are dotted.
(E) Mutagenesis of the Phe residues of b-arrestin DxxFxxFxxxR motif prevent the binding of AP2 complexes to GST-b-arrestin C1 in brain extracts.
(F) Conservation of the interaction motif between arrestins and ARH and possible motifs from epsin and CVAK90.
DOI: 10.1371/journal.pbio.0040262.g005
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Changing Hubs in CCP Maturationthe AP2 adaptor complex resulting in efﬁcient cargo
recognition [32].
We conclude that AP2 is the major accessory protein
recruiting hub in early stages of clathrin-coated pit assembly.
Changing Hubs
To look at the behaviour of b-appendage interactors in
vivo (Figure 7), we chose b-arrestin (which binds directly to
either adaptors or clathrin) and Eps15 (which only binds to
adaptors). When expressed as GFP-fusion proteins, the C-
terminal clathrin/adaptor interacting domain of b-arrestin2
constitutively targets to CCPs as shown by their co-local-
isation with AP2 adaptors (Figure 7A, a and b). This co-
localisation was completely lost when the residues in b-
arrestin shown to be required for efﬁcient binding to b-
appendage were mutated to alanines (F6,F 9 and R13 in our b-
arrestin P-long peptide) (Figure 7A, c–h). In contrast to the C-
terminal domain, full-length b-arrestin only co-localises with
AP2 after GPCR receptor activation [33]. Full-length b-
arrestin2 translocates to coated pits on receptor activation,
but an F389 mutant (F6 in our peptide) does not co-localise
(Figure 7B). We would conclude that b-arrestin is recruited
into coated pits via the AP2 b2 appendage, as a mutant of this
interaction abolishes it. Based on the competition data above
(Figure 5E) we would suggest that once b-arrestin is in the
coated pit it is likely maintained there by changing its hub
afﬁliation from AP2 to clathrin. In clathrin-coated vesicles
from both liver and brain, APs are under-represented
compared to clathrin [15], and thus the terminal domains
will not be fully occupied and are free to accommodate the
displaced b-arrestin. In in vitro pull-downs of GST-b2-
appendageþhinge there is not an excess of clathrin (see
Coomassie staining in Figure 6A and 6B) and thus b-arrestin
is displaced. In contrast GFP-Eps15-MD domain is cytoplas-
mic and is not enriched in coated pits like b-arrestin. Eps15
has no interaction with clathrin and must be displaced as
clathrin assembles. Given that it cannot rebind to clathrin it
will be pushed to the edge of coated pits where free adaptors
are being recruited [8,13,34]. This concentration of Eps15 at
the edge of coated pits has been previously observed by
electron microscopy [35] and is not enriched enough to be
visible in immunoﬂuorescence. Thus despite the higher
avidity of the motif domain of Eps15 for AP2, compared to
b-arrestin which has only one AP2 interaction site, it is not
concentrated in clathrin-coated structures (Figure 7A).
Our data do not agree with others who claim that clathrin
binds to the side site and thus ligands of the top site can
remain in coated pits during maturation [25]. We conclude
that changing hubs is the main reason for the maintenance of
accessory proteins and adaptors during coated pit matura-
tion. Thus b-arrestin is displaced from the AP2 hub by
clathrin, but is able to rebind to the excess of clathrin
terminal domains found in coated pits.
Discussion
Our structural, proteomic and mutagenesis data show that
endocytic proteins that bind predominantly to the top site of
the a-appendage also interact predominantly with the side
site of the b-appendage via different motifs. This leaves space
for yet other proteins to interact with the top site of the b-
appendage and the side site of the a-appendage and thus the
AP2 appendages can initially be considered as scaffolds for
protein assembly. It is interesting to note that: a) we can no
longer assume that only unstructured linear peptide motifs
are bound by appendages; b) we can no longer assume from
site conservation that we can guess the binding motif; and, c)
we can now assume that multiple regions of all appendage
domains are used by interactors. There are 2 main sub-
domains to most appendages (for review of appendages in
COP and clathrin coat components and in GGAs see [3]) and
it appears that each of these sub-domains has an independent
interaction site for ligands. For the a-appendage both
interaction sites can be used by the same protein to increase
its afﬁnity substantially while still remaining readily rever-
sible [8] and this is also likely true for many b-appendage
ligands given that mutations of either site reduce binding
(Figure 2B).
The b-Appendage Top and Side Sites
So far appendage domains have been shown to bind to
unstructured linear peptides in generally unfolded regions of
proteins which we call motif domains (MDs). We and others
now show that the top site of the b-appendage is different in
that it confers an a-helix conformation to b-arrestin and
ARH peptides (see Figure 5 and [25]). Thus not only are there
charge and hydrophobic components to the interaction but
extra speciﬁcity is conferred by the requirement that the
sequence folds into a helix with the interacting residues on
one face of the helix. The C-terminal region of b-arrestin that
contains the b-appendage binding motif is poorly structured
in the b-arrestin structure and the critical Phe residues are
pointing towards the core structure [36]. Thus it is likely that
some switch is needed to reveal the sequence to the b-
appendage for recruitment to sites of endocytosis. While we
show that b-arrestins and ARH can interact using a helix
motif of the form DxxFxx[F/L]xxxR we must also note that
the conserved interaction surface could be used for other
modes of peptide interaction. Also, the R879A mutant of the
b-appendage binds to an arrestin peptide with a higher
afﬁnity than wild-type and thus the interaction is not
optimised for the highest afﬁnity. This is often observed in
nature where there is a balance of afﬁnity versus speciﬁcity.
The side site on the b-sandwich sub-domain is in a different
location to the side site on a, c and GGA appendages. It is
centred around Y815 which forms part of a hydrophobic
groove. In the structure of Eps15 P-short bound to the b-
appendage this hydrophobic groove is occupied by an F
followed by a tight turn of the peptide and a critical DF
sequence. As with the top site of a-appendage there may be
many possible sequences that can occupy this site, giving the
opportunity for many different ligands to bind to this site on
the appendage.
We still do not know why two different appendages are
required but given that the same set of proteins are
interacting with the top of a and the side of b, we can
suggest there may be cooperativity in the interactions of both
appendages with ligands.
Building the Endocytic Interactome
b1 and b2 adaptors are highly homologous, while b3 has
weak homology but no clear conservation of known inter-
action sites. b4 has similar weak homology and only has the
platform sub-domain with clear conservation of the residues
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not see major interaction partners for b3 and b4 (Figure 6B).
Thus the interactors have lower afﬁnity and perhaps one
needs the correct combinations of appendages as found in
AP3 and AP4 complexes to get higher avidity interactions.
One can propose that these appendages are not used to
aggregate cargo by cross-linking and thus the avidity effects
we see with accessory protein interactions need not exist. It
Figure 6. Introducing the Clathrin Hub
(A) Displacement of b-appendage interactors with clathrin binding. A comparison of protein interactors with the b-appendageþ/ the connecting linker
to the core of the adaptor complex (the hinge domain) is made. Rat brain extract was used. The asterisks point to a reduced binding of Eps15 to the
Y888V mutant only when clathrin is present. It can be noted that b-arrestin is not enriched in the pull-downs over total lysates (where 1% of the volume
used for the pull-down is loaded) and given the high affinity of arrestins for the b-appendage we conclude that only a small percentage of the arrestin is
in the ‘‘open’’ conformation necessary for b-appendage binding. Amphiphysin is also not enriched, but it has a much lower affinity for the b-appendage.
(B) b1 appendageþhinge binding to clathrin results in reduced accessory protein interactions. Appendage and appendageþhinge proteins from b1t o
b4 adaptins and their interactors are compared. We found no specific bands by mass spectrometry that interact with b3 and b4 in these experiments
(apart from chaperones) See Figure S3 for b1–4 appendage homologies.
(C) Clustered clathrin N-terminal domain interactions with accessory proteins. The GST-b-propeller domain has been bound to sepharose beads and
thus we should especially detect proteins that can bind to clathrin via multiple interactions.
(D) Clathrin binding of MDs from various accessory proteins except Eps15. GST-MDs on beads were incubated with rat brain extract and clathrin was
detected by Western blotting.
DOI: 10.1371/journal.pbio.0040262.g006
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formation but clathrin does bind to the b3-appendageþhinge
protein (Figure 6B). To understand the interactions of AP1
and AP2 complexes we should also consider the network of
interactors with both appendages and with clathrin. In Figure
8 we plot an updated network for the a- and b2 appendages
(Figure 8A). While these diagrams do not give information on
afﬁnities and competition between ligands, we do begin to see
the importance of knowing the context in which each protein
operates. Given the concentrations of protein interactions on
Figure 7. Selection of Partners to Remain during Coated Pit Maturation; b-Arrestin but not Eps15 Co-Localise with AP2 Adaptors in CCPs
(A) GFP-barrestin2 C-terminal domain co-localisation with AP2 adaptors while mutants are cytoplasmic. GFP-Eps15-MD is cytoplasmic.
(B) Full length GFP-b-arrestin2 co-localisation with AP2 adaptor following stimulation of GPCR receptors with TRH for 15s. A mutant of b2-appendage
interaction does not localise to coated pits.
DOI: 10.1371/journal.pbio.0040262.g007
Figure 8. Network Dynamics
(A) Network of protein interactions of AP2 appendages and clathrin. The a- and b2-appendage interaction data are from our mass spectrometry analysis
and from the literature. The AP2 hub (yellow shaded area) is made up of 2-sub-hubs that increase the interactome repertoire (side arms) but for the
majority of proteins they increase the interaction avidity (central circle). As the network matures and clathrin is recruited, many of the previous
interactors become clathrin interactors (green shaded area). Of the remaining proteins we only know of a few that do not bind to clathrin, while others
have simply not been tested.
(B) Limiting the mobility of appendage domains by interactions of both domains with the same accessory protein.
(C) The changing environment of adaptor protein complexes, A, in CCV formation, showing the gradual movement from simple affinity based
interactions with accessory proteins, B, to avidity based interactions, once adaptors are recruited to the membrane. As the coated pit matures and
clathrin, C, polymerises into a matrix then accessory proteins that cannot bind directly to clathrin are displaced to the edge where the pit is still
growing. ATP hydrolysis is needed to depolymerise clathrin and re-prime the system.
DOI: 10.1371/journal.pbio.0040262.g008
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Changing Hubs in CCP Maturationa- and b-appendages it is easy to understand why over-
expression of appendage interacting domains from almost
any protein will inhibit CCV formation.
Understanding CCV formation as a network of protein
interactions can help us not only simplify the complex
interactomes into core and peripheral parts, but it also helps
us design our experiments. In a network each interaction of
necessity must be of relatively low afﬁnity if the network is to
be dynamic. The meta-stable nature of complexes formed
allows the network to evolve from one hub to another with
directionality imposed by steps that are not readily reversible.
In this view of CCP assembly, over-expression of many
proteins within the network may well inhibit endocytosis
while over-expression of a central hub in the process should
have no effect. Likewise depletion of the hub proteins should
inhibit while depletion of the more peripheral node proteins
will in general be less dramatic. Thus the position of a protein
in a network is an important consideration when adding GFP
tags to proteins to probe their function. Additionally,
keeping the levels of over-expressed protein close to those
found for endogenous proteins is important, if a dominant-
negative effect is not sought. The network of interactions also
provides many points of contact with other cellular processes
(like exocytosis and signalling pathways) and the dynamic
nature provides many avenues to modulate endocytosis.
Our data raise questions as to the purpose of two different
appendages in each adaptor complex. There are several
consequences: a) it increases the range of proteins that can be
bound to the AP complexes; b) if the same protein is bound to
both appendages then this increases the avidity of the
interaction; c) the multiple independent interaction sites on
appendages provide an increased speciﬁcity to the inter-
actions; and, d) the use of two appendages binding to one
ligand should limit the mobility of the appendages in space
(Figure 8B). Thus when linked, the ﬂexible appendages will be
constrained to mobility primarily in one plane, making it
more likely that the ligands will be recruited back to the core
of the adaptor complex.
How CCV Endocytosis Works
We propose the following sequence of events for coated pit
maturation (Figure 8C). The coincidence of multiple acti-
vated cargo receptors and PtdInsPs in the membrane results
in the accumulation of adaptor complexes. Once adaptors are
in close proximity to each other they become stabilised by
cross-linkages using accessory proteins with multiple inter-
action sites for adaptor appendage domains. Many of these
accessory proteins in turn recruit clathrin, and once this is
concentrated at the site of the nascent vesicle it self-
assembles. At this point the interactions between clathrin
and the adaptors are no longer strictly ‘‘liquid-phase’’ and
thus afﬁnity measurements and dissociation constants do not
accurately reﬂect the dynamics of the system. The clathrin
coat makes a pseudo ‘‘solid-phase’’ interaction with the
adaptor proteins, thus displacing the high avidity accessory
protein interactions with much weaker clathrin:adaptor
interactions. This means that off-rates for clathrin monomers
in the coat are dramatically reduced thereby increasing the
effective afﬁnity for adaptors. This is quite different from the
avidity effects we observe with accessory protein interactions
where the off-rate should not signiﬁcantly change. A dynamic
instability in the process thus favours a forward direction
only in the presence of sufﬁcient cargo and the ultimate
energy input is at the ﬁnal stage of vesicle scission (GTP
hydrolysis) and uncoating, where ATP is used to disassemble
the clathrin coat enabling a return to liquid-phase afﬁnities.
Similarly it appears that ATP hydrolysis occurs in membrane
fusion only after fusion has taken place [37] and this again is
likely to give a dynamic instability until late in the process.
Thus two basic principles are deduced: 1) High avidity
interactions of accessory proteins are replaced with what are
apparently the weak interactions of the clathrin coat with
adaptors. However these ‘‘matricity’’-driven interactions are
stable because the ‘‘off-rate’’ of clathrin monomers is now not
a major factor. Hydrolysis of ATP displaces the clathrin coat
thus re-priming the system. 2) Looking at CCV formation
from an energetic point of view it might appear that the
process is being pulled forward from the end point, where
ATP hydrolysis is used to re-prime the clathrin coat protein.
This makes good sense as the system has been designed with
built-in instability and the point of no return is very late in
the process. Thus initially low afﬁnity (and therefore readily
reversible) interactions between cargo and adaptors, between
adaptors and accessory proteins, and between accessory
proteins and clathrin, are used to build the network.
Gradually the network becomes more stable and only then
does it become necessary to utilize the energy from ATP
hydrolysis to go to the next stage, and at this point CCV
formation has already occurred.
Materials and Methods
Constructs. GST-mouse-a-appendage (a-earL695–983), GST-hu-
man-b2-appendage (700–937), 63 His-human-b2-appendage (700–
937), GST-human-b2-appendageþhinge (616–937), GST-mouse-b1-
appendage (707–943), GST-mouse-b1-appendageþhinge (512–943),
GST-human-b3-appendage (853-1094), GST-human-b3-appenda-
geþhinge (810-1094), GST-human-b4-appendage (570–739) (AHWAT
to end), GST-human-b3-appendageþhinge (535–739) (SPKSD to
end), and GST-mouse-c-appendage (E3, 704–822) were expressed
in the BL21 strain of E. coli. All proteins used for ITC and
biochemistry were puriﬁed via afﬁnity resins, Q-sepharose and gel
ﬁltration before use. For ITC experiments, thrombin cleaved a and
63 Hisb2 or GSTb2 were used after puriﬁcation by afﬁnity resins
and gel ﬁltration. Mutations were made by PCR mutagenesis and
constructs were sequenced. All the key a-appendage mutants are
well folded as monitored by the stoichiometry of binding in ITC
experiments but the b-appendage mutants are less stable and
precipitate over time.
63 His human Eps15-MD (530–791) (STSSSE...GKRSI) was cloned
into EcoR1/Not1 sites of pET28c and a GST version was cloned into
same sites of pGex4T2. GST rat epsin1-MD (249–401) (TGGKE...D-
TEPD) was cloned into EcoR1/Not1 sites of pGex4T2 and thrombin
cleaved for ITC measurements.
GST human-b-arrestin2-C1 (317–410) and full length GST bovine-
b-arrestin2 were used. GST rat AP180-MD (516–915)
(ATAPS...IKDFL) was cloned into ER1/Not1 sites of pGex4T2. The
GFP-tagged constructs were derived from rat b-arrestin2, the C-
terminal tail fragment C1 (317–410) and mutations F389A, F392A,
and R396A were made by PCR and constructs were sequenced.
GST rat Amph1-MD (1–390) (start... WTTSTD) was cloned into
the ER1/Not1 sites of pGex4T1. Has DNF, DPF, and WxxW adaptor
binding sites and the N-terminal BAR domain which will dimerise the
protein.
GST bovine clathrin terminal domain residues 1–363 were used.
Fishing in HeLa cell extracts with GST-appendages. HeLa cells (13
10
8 cells) were trypsinised and washed in 150 mM NaCl, 20 mM
HEPES [pH7.4] with 2 mM DTT and protease inhibitors. Cells were
solubilised with NP40 (not to disrupt the nuclei) and debris was
pelleted. For interaction experiments 0.1% Tx-100 was added to 0.6
ml of this extract þ 30–100 lg of GST fusion-protein þ glutathione-
sepharose beads, incubated for 1 h at 4 8C and then the bead bound
proteins were washed 43 with the same buffer with Tx-100.
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protein bands were separated by liquid chromatography on a reverse
phase C18 column (150 3 0.075 mm i.d., ﬂow rate 0.15 ll/min). The
eluate was introduced directly into a Q-STAR hybrid tandem mass
spectrometer (MDS Sciex, Concord, Ontario, Canada). The spectra
were searched against a NCBI non-redundant database with
MASCOT MS/MS Ions search (http://www.matrixscience.com). For
protein with a low number of peptides we have conﬁrmed their
identity by searching the PeptideSearch nrdb database using
sequence tags from our data. Proteins in the same molecular range
as the GST-appendages were sequenced from pull-downs where the
appendages were cross-linked to beads (Afﬁgel 10) to reduce the
signal from the pull-down proteins.
Crystallography and structure determination. 63 His-tagged b-
appendage was expressed by overnight induction in BL21 pLysS cells.
Protein in 20 mM HEPES, 150 mM NaCl, and 2 mM DTT was puriﬁed
by passage over a Ni-NTA column after which the 63 His tag was
cleaved off by a 2.5-h incubation with thrombin. The protein was
subsequently puriﬁed further by passage over a Q sepharose column
and a gel ﬁltration column. Protein was concentrated to approx-
imately 4 mM and ﬂash frozen in liquid nitrogen for long-term
storage. The crystal of the co-complex of b-appendage and b-arrestin
P-long was obtained by vapour diffusion using sitting droplets,
against a reservoir containing 0.2 M magnesium formate, 20% PEG
3350. Droplets were made by mixing 100 nl b-appendage:peptide mix
(1.11:1.88 mM) with 100 nl of the reservoir. A solitary crystal grew
over a period of a few weeks. Despite exhaustive attempts, crystals
could not be regenerated. The crystal was cryoprotected by transfer
to a buffer containing 0.2 M Mg formate and 30 % PEG3350. Data
were collected at ID14–1 and ID14–4 at the European Synchrotron
Radiation Facility, k ¼ 0.934 A ˚ and k ¼ 0.980 A ˚ . The crystal was split
and highly anisotropic so we could only collect an incomplete dataset
to 2.5A ˚ . The crystal belonged to space group P212121, with unit cell
dimensions 36.95, 35.37, 190.85A ˚ .
Crystals of the b-appendageþEps15 P-short peptide were grown by
vapour diffusion, using sitting droplets, against a reservoir containing
2 M ammonium sulphate and 0.1 M sodium acetate [pH 4.5]. Droplets
were made by mixing 1 ll of the protein-peptide mix (1:2 mM) with 1
ll of the reservoir solution. Crystals grew over a few months. The
crystals were cryoprotected by transfer to a buffer containing 1.82 M
(NH4)2SO4, 0.09 M NaOAc, 25 % glycerol. Crystals belonged to space
group P212121 with unit cell dimensions 58.33, 71.97, 115.90 A ˚ , with
two molecules in the asymmetric unit. Data were collected at ID14–4
at the European Synchrotron Radiation Facility, k ¼ 0.979A ˚ . Crystals
were of excellent quality and a complete dataset was collected to 1.9 A ˚ .
Data were integrated using MOSFLM [38] and scaled using SCALA
from the CCP4 suite of crystallographic software [39]. The structure
was solved by molecular replacement using PHASER [40], using the
structure of b2 adaptin chain A (PDB ID 1E42) as the search model.
The model was corrected and completed using O and COOT and the
structure was reﬁned using REFMAC5 [41–43].
Coordinates and structure factors were deposited in the Protein
Data Bank [44] with the accession codes 2iv8 (b-appendage with b-
arrestin peptide in top site)and 2iv9 (b-appendage with Eps15 peptide
in side site). Figures were generated using Aesop (Martin Noble,
personal communication) and schematics of peptide-protein inter-
actions were based on the output of LIGPLOT [45]. Surface potential
maps were calculated using GRASP [46] and displayed in Aesop.
Surface plasmon resonance. SPR experiments were performed
using a BIA2000 apparatus (BIAcore, Uppsala, Sweden). GST, GST-a,
or GST-b2 were immobilized via amine coupling (according to
manufacturer’s instructions) on a CM5 (carboxymethyl) chip.
Recombinant 63His hEps15-MD was then injected at a concentration
of 300 nM to saturate the surface. Running buffer was 20 mM HEPES,
150 mM NaCl, [pH 7.4]. Dissociation was measured over 7,000 s at a
ﬂow rate of 20 ll/min. Nonspeciﬁc binding was measured as 63 His
hEps15-MD binding to the GST surface and subtracted from the
experimental data. SPR data was analyzed using BIAevaluation
software provided by the manufacturer.
Isothermal titration calorimetry. Binding of peptides and proteins
to appendage domains was investigated by ITC [47] using a VP-ITC
(MicroCal, Northampton, Massachusetts, United States). This techni-
que allows us to calculate equilibrium association or dissociation
constants for interactions. These are distinct from association and
dissociation rate constants measured by surface plasmon resonance.
Where we can accurately measure the concentrations of protein/
peptides used we can get accurate values for the stoichiometry of
interactions. Where proteins are not a single species due to
degradation then the stoichiometry may be inaccurate but the
afﬁnity can still be measured if the concentration of the ligand in the
syringe is accurate. All experiments were performed in 100 mM
HEPES, 50 mM NaCl, 2 mM DTT [pH 7.4] at 10 8C and protein
concentrations were determined by absorbance at 280 nm or at 257
nm. The peptides or proteins were injected from a syringe in 40–50
steps up to a 3–5 fold molar excess over the cell concentration. The
cell contained 1.36 ml protein solution and typically the ligand was
added in steps of 4–8 ll every 3.5 min. Concentrations were chosen so
that the binding partners in the cell were at least 5-fold higher than
the estimated dissociation constant, if possible. The ligands in the
syringe were again at least 10-fold more concentrated. The heat of
dilution of the ligand was subtracted from the data prior to ﬁtting.
Titration curves were ﬁtted to the data using the ORIGIN program
supplied by the manufacturer yielding the stoichiometry N, the
binary association constant Ka (¼ Kd
 1) and the enthalpy of binding.
The entropy of binding DS8 was calculated from the relationship DG8
¼  RT lnKa and the Gibbs-Helmholtz equation. Peptides were
purchased at . 95 % purity from the Institute of Biomolecular
Sciences (University of Southampton, United Kingdom) and weighed
on an analytical balance and veriﬁed by measuring the OD280 or
OD257. The resulting concentration errors are estimated to be ,
10%. Unless otherwise stated the values for the stoichiometry, N,
were within this error region around N ¼ 1.
Cells transfections and immunoﬂuorescence. HeLa cells (ATCC)
were grown in DMEM supplemented by 10% foetal bovine serum
(Invitrogen, Paisley, United Kingdom). Cells were transiently trans-
fected with GFP constructs and AP2 was detected with monoclonal
antibody 100.2 (Sigma, St. Louis, Missouri, United States). Thyro-
tropin releasing hormone (TRH) was from Sigma. For immunoﬂuor-
escence HeLa cells on coverslips were used for immunoﬂuorescence
studies the day after transfection. Cells were washed in PBS and ﬁxed
in 3.7% paraformaldehyde 0.03 M sucrose for 30 min at 4 8C, then
washed once in PBS and quenched in 50 mM NH4Cl in PBS. The cells
were then incubated with primary antibodies in permeabilization
buffer (PBS supplemented with 1mg/ml BSA and 0.1% triton X-100)
for 45 min at room temperature. After two washes with PBS 1mg/ml
BSA, cells were incubated for 45 min at room temperature in PBS 1
mg/ml BSA containing secondary antibodies. After two washes in
permeabilization buffer and one in PBS, the cells were mounted on
microscope slides in PBS-glycerol (50/50).
Samples were examined under an epiﬂuorescence microscope
(Leica, Wetzlar, Germany) with a cooled CCD camera (Micromax,
Princeton Instruments Lurgan, United Kingdom). Images were
acquired with MetaMorph (Universal Imaging, Downingtown, Penn-
sylvania, United States) and processed with MetaMorph, NIH image
(http://rsb.info.nih.gov/nih-image) and Photoshop (Adobe Systems,
San Jose, California, United States).
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Figure S1. Fishing in Rat Brain/Liver Cytosol with GST-Appendages
Found at DOI: 10.1371/journal.pbio.0040262.sg001 (1.9 MB TIF).
Figure S2. Schematics of Short Peptide Motifs and Domains in New
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Found at DOI: 10.1371/journal.pbio.0040262.sg002 (2.3 MB TIF).
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Accession Numbers
The PubMed (http://www.ncbi.nlm.nih.gov/entrez/query.fcgi) acces-
sion numbers for the genes and gene products presented in this
paper are AAK (NP_055726), aftiphilin (Q6ULP2), amphiphysin1
(P49418), AP180 (NP_113916), ArfGAP1 (CAG30268), ARH
(AAH29770), auxilin (BAA32318), a-adaptin (P18484), b2-adaptin
(P63010), b-arrestin2 (P32121), CALM (AAB07762), clathrin
(NP_004850), Dab2/Disabled2 (AAF05540), epsin1 (NP_037465),
epsin2 (O95208), epsinR (Q14677), Eps15 (CAI13030), Eps15R
(NP_067058), HivRevBP (NP_004495), Hsc70 (NP_006588), inter-
sectin1 and 2 (NP_001001132, AAF63600), KIAA0196 (BAA12109),
KIAA0592 (AAH82258), KIAA0685 (XP_217014), KIAA1033
(BAA82985), KIAA1096 (BAA12109), KIAA1219 (BAA86533),
KIAA1414 (XP_343001), KIAA1558 (BAB13384), RalBP1
(AAK34942), RanGAP1 (NP_055805), Scy1-like1/CVAK90
(NP_065731), Scy1-like2/CVAK104 (NP_060458), Sec23 interacting
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Changing Hubs in CCP Maturationprotein p125 (Q9Y6Y8), sorting-nexin9/snx9 (NP_057308), pacsin/
syndapin2 (AAH08037), c-synergin (AAD49732), Tom1 (NP_005479),
and Znﬁnger protein (NP_115765).
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